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TMCM-41 silica nanoparticles were used as inorganic scaffolding to prepare a nanoscopic-capped hybrid 
material S1, which was able to release an entrapped cargo in the presence of certain enzymes, whereas in 
the absence of enzyme, a zero release system was obtained. S1 was prepared by loading nanoparticles 10 
with safranine O dye and was then capped with a gluconamide derivative. In the absence of enzyme, the 
release of the dye from the aqueous suspensions of S1 was inhibited as a result of the steric hindrance 
imposed by the bulky gluconamide derivative, the polymerized gluconamide layer and the formation of a 
dense hydrogen-bonded network around the pore outlets. Upon the addition of amidase and pronase 
enzymes, delivery of safranine O dye was observed due to the enzymatic hydrolysis of the amide bond in 15 
the anchored gluconamide derivative. S1 nanoparticles were not toxic for cells, as demonstrated by cell 
viability assays using HeLa and MCF-7 cell lines, and were associated with lysosomes, as shown by 
confocal microscopy. Finally, the S1-CPT material loaded with the cytotoxic drug camptothecin and 
capped with the gluconamide derivative was prepared. The HeLa cells treated with S1-CPTunderwent 
cell death as a result of material internalization, and of the subsequent cellular enzyme-mediated 20 
hydrolysis and aperture of the molecular gate, which induced the release of the camptothecin cargo. 
 
INTRODUCTION 
The preparation of hybrid functional materials in an attempt to 
mimic objects that perform active tasks in living organisms is a 25 
fertile multidisciplinary research area1. Nature uses simple 
molecules (amino acids, saccharides, nucleobases and certain 
inorganic compounds) to design functional structures (channels, 
pumps, gates) of a nanometric size. Chemists, inspired by these 
biological systems, have started to develop nanometric functional 30 
materials that work similarly to these complex structures in living 
organisms2.  
 One of the most appealing concepts in nature is related with 
channels that act as gates and control mass transport on-
command. Inspired by this concept, researchers have recently 35 
been involved in the design of “molecular gates”3. A molecular 
gate can be defined as a nanoscopic system in which mass 
transport (or delivery) can be triggered by a target external 
stimulus, which is able to control the state of the gate (closed or 
open) at will. In general, an abiotic gated material is composed of 40 
two subunits: (i) a suitable inorganic support and (ii) certain 
organic molecules, usually grafted on the external surface, which 
are the responsible for mass transport/delivery control.   
 In most prepared gated materials, silica mesoporous supports 
of the MCM-41 family have been used as inorganic scaffolds. 45 
This is due to the special properties of these materials, such as 
large load capacity, biocompatibility, high thermal stability, 
homogeneous porosity, inertness, and tunable pore sizes with a 
diameter of ca. 2-10 nm. In addition, the existence of well-known 
surface functionalization procedures makes these scaffoldings 50 
suitable to develop molecular gated systems.  
 Since the first example of a gate-like ensemble based on 
mesoporous materials was described by Fujiwara et al.,4 many 
different molecular gated organic-inorganic hybrid materials 
using a wide range of different chemistries have been reported.5 55 
Following this pioneering work, several research groups have 
demonstrated that it is possible to design gated materials capable 
of achieving “zero release”, which can be fully opened by 
applying certain external stimuli. Both physical and chemical 
triggers, such as pH,6 temperature,7redox potential,8 light9 or 60 
reaction with chemical species,10 have been reported. Most 
systems have been designed for drug delivery applications, 
although sensing protocols using molecular gated supports have 
also been described10b,c,d. 
 Despite the fact that molecular gated devices have been studied 65 
over the last few years, the use of silica mesoporous gated-like 
devices involving biomolecules like caps or stimuli to deliver the 
cargo has not been fully explored. For instance, a few examples 
using specific drugs as cargo,11 biomolecules as capping agent,12 
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or enzymes as external stimuli13 have been described. In 
particular, very few examples using enzymes have been reported 
and most cases have focused on peptide-capped nanocontainers 
capable of releasing their cargo in the presence of the appropriate 
peptidase.13e,f  The development of enzyme-responsive bio-gated 5 
mesoporous silica nanoparticles is appealing taking into account 
the wide range of available enzymes able to selectively catalyse a 
large number of different chemical reactions. In particular, the 
possibility of prepare tailor-made sequences, that may provide 
fine selectivity in the design of advanced gate-opening devices, 10 
opens new perspectives of applicability for drug delivery systems 
using mesoporous nanoscopic gated systems. 
 The use of molecular gated devices based on mesoporous silica 
nanoparticles as drug containers offers very promising 
applications in the field of medicine as they would allow the 15 
controlled and specific deliver of the drug in the target organ, 
thus avoiding degradation of the drug by other physiological 
agents.14 The application of these concepts in antitumoral 
medicine has become an area of great interest.15 Thus, the 
research community is making great efforts to develop new, 20 
innovative mass transport devices capable of delivering 
anticancer drugs on tumour cells. 
 By bearing in mind the fact that there are very few examples of 
gated materials based on the enzymatic hydrolysis of capping 
groups and taking into account the potential applications of such 25 
systems to develop nanodevices showing a “zero release” before 
the presence of target enzymes, we report herein the design of 
new and simple capped nanoparticles displaying enzyme-induced 
delivery. Mesoporous silica nanoparticles were used as inorganic 
scaffolding while their external surface was functionalized with a 30 
gluconamide derivative capable of being hydrolyzed in the 
presence of the corresponding specific amidases both in vitro and 
on intracellular media. Materials’ efficiency was tested using dye 
molecules as the cargo to prove both the delivery profiles and the 
non toxicity of the silica nanoparticles in cells. Moreover, 35 
camptothecin- (CPT) loaded nanoparticles were proved to cause 
cell death in several cancer cell lines.  
RESULTS AND DISCUSSION 
Design and synthesis of gated materials 
Application of supramolecular chemistry principles to design 40 
gate-like ensembles based on mesoporous scaffoldings allows the 
development of nanoscopic devices for mass transport and 
controlled release applications. As stated in the Introduction, 
most developed gated materials employ 
molecular/supramolecular interactions for the fine control of 45 
cargo delivery. In contrast, relatively few examples use 
biomolecules for capping or uncapping protocols. Following our 
interest in applying biological interactions, as triggered for 
control delivery, here we paid attention to using enzymes as 
“biological-keys”.  50 
 Our aim was to design biocompatible easy-to-prepare capping 
systems in order to synthesize simple gated scaffoldings capable 
of being used efficiently in delivery applications. With this 
approach, silica mesoporous MCM-41 nanoparticles were 
selected as inorganic scaffolds. Scheme 1 shows the proposed 55 
enzyme-driven gate-opening mechanism for the new gated 
material S1. In order to prepare the designed material, the pores 
of the MCM-41-type nanoparticulated scaffolding were loaded 
with safranine O. Then the external surface was functionalized 
with N-(3-triethoxysilylpropyl)gluconamide to yield the final 60 
hybrid material S1. This organic compound has been selected by 
bearing in mind the presence of an amide hydrolysable group and 
five hydroxyl groups, which were expected to result in a dense 
hydrogen-bonded network around the pore outlets, which should 
avoid cargo delivery. In the presence of the appropriate amidase, 65 
the amide bond is hydrolyzed with the subsequent reduction in 
size of the attached capping molecule and, consequently, the 
delivery of the cargo. In order to completely block the drug inside 
the mesopores in the absence of amidase (to favor a selective 
drug release), we used a higher proportion of N-(3-70 
triethoxysilylpropyl)gluconamide if compared to previous works 
of our group (vide infra). Under these conditions, and together 
with the direct silica surface functionalization (by the interaction 
of the silanol groups with the triethoxy moieties of the silane), a 
certain polymerization of the silane on the silica surface was 75 
expected (in this last case, by using a limited number of silanol 
groups to maintain the interaction with the support). Thus, this 
strategy guarantees the formation of a thicker shell around the 
mesoporous silica nanoparticles. However, regardless of the 
nature of the incorporated silanes (directly functionalized or 80 
polymerized), the enzyme was expected to be able to cut the 
organic arms inducing the drug release. 
 
Scheme 1 Schematic representation of the synthesis procedure and the 
gate-opening mechanism of S1 in the presence of the appropriate enzyme. 85 
 
 The silica nanoparticulated material (a calcined MCM-41-like 
solid) was prepared by following well-known procedures using 
TEOS as the hydrolysable inorganic precursor and the surfactant 
hexadecyltrimethylammonium bromide (CTABr) as the porogen 90 
species16. Moreover N-(3-triethoxysilylpropyl)gluconamide is a 
commercially available alkoxysilane derivative, which was 
selected and used as the molecular gate.  
 In order to ensure the correct functionality of the final hybrid 
material, we followed a two-step synthetic procedure which we 95 
and others have previously used to prepare gated structures 
containing a loaded cargo on the pores and suitable switchable 
ensembles on the pore outlets.6e In the first step, the efficient 
loading of pores was achieved by stirring a highly concentrated 
Safranine O solution in the presence of the mesoporous 100 
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nanoparticles. Then in a second step, the gluconamide derivative 
was added to the same mixture to functionalize the external 
surface of the siliceous material. Following this protocol, the 
anchoring reaction of N-(3-triethoxysilylpropyl)gluconamide 
occurred on the nanoparticles containing pores filled with 5 
safranine O in a suspension which still contained a high 
concentration of the dye, thus inhibiting dye diffusion from the 
inner pores to the bulk solution and, at the same time, hampering  
as much as possible the entrance of N-(3-
triethoxysilylpropyl)gluconamide into the porous network.  10 
 
 Fig. 1 XRD Patterns for the nanoparticulated MCM-41 as-synthesized 
(i), calcined MCM-41 nanoparticles (ii), S1 (iii) and S1-CPT (iv). 
 
 Following this protocol, the final S1 material should contain 15 
the gluconamide derivative, mainly as a shell on the external 
surface (vide infra for a more detailed comment), whereas 
safranine O should be located inside the mesopores. Finally, the 
violet/pinkish solid S1 was filtered, washed with water and dried 
at 40°C for 12 h. 20 
 A second solid, S1-CPT, was prepared following the same 
procedure as cited above. In this case, mesopores were filled with 
the anticancer agent campthotecin, and the uptake was performed 
in acetonitrile-ethanol mixtures to favor drug dissolution. Then, 
N-(3-triethoxysilylpropyl)gluconamide was added to the 25 
suspension and the final material was isolated by filtration, 
washed with chloroform-methanol 3:4 v/v and dried at vacuum 
for 1 h.  
Characterization of solids 
The prepared material S1 was characterized by standard 30 
techniques. Figure 1 shows the powder X-ray diffraction (XRD) 
patterns of solids MCM-41 as synthesized, MCM-41 calcined, S1 
and S1-CPT. The XRD of the mesoporous MCM-41 material as-
synthesized (Figure 1, curve i) displayed the expected four peaks 
of a hexagonal ordered array indexed as (100), (110), (200), and 35 
(210) Bragg reflections. From the XRD data, an a0 cell parameter 
of 41 Å (d100 spacing of 36.05 Å) was calculated. In curve ii, 
corresponding to the MCM-41 calcined sample, a significant shift 
of the (100) reflection in the XRD is clearly observed. This 
displacement, together with the broadening of the (110) and (200) 40 
reflections, corresponds to an approximate cell contraction of ca. 
6-8 Å due to the condensation of silanols groups in the 
calcination step. Figure 1 also depicts the XRD patterns for solids 
S1 and S1-CPT. For these materials, reflections (110) and (200) 
were lost, most likely due to a reduced contrast as the result of the 45 
loading and functionalization process. Yet the presence of the d100 
peak in the XRD patterns in both S1 and S1-CPT suggested that 
the pore loading (with Safranine O dye or with the campthotecin 
drug) and functionalisation process did not modify the 
mesoporous MCM-41 scaffolding. 50 
 
Fig. 2 Representative Transmission Electron Microscopy (TEM) image of 
the calcined MCM-41 nanoparticles (A) and the loaded and 
functionalized  mesoporous silica nanoparticles (S1) (B). 
 55 
 
 
 
 
 60 
 
 
Fig. 3 Statistical representation of particle size obtained by DLS 
(Dynamic Light Scattering) studies. The average size of nanoparticles of 
calcined MSN (straight), S1 (dash) and S1-CPT (dot) was found to be ca. 65 
100 nm. 
 
Fig. 4  Nitrogen adsorption-desorption isotherms for (a) the MCM-41 
mesoporous nanoparticles (b) S1. Insets: Pore size distribution of each 
material. 70 
  
 Preservation of the mesoporous structure in the final 
functionalized solid S1 was also confirmed by the Transmission 
Microscopy (TEM) images. Figure 2 shows the morphology of 
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the prepared mesoporous materials. MCM-41 scaffolding was 
obtained as spherical particles showing a mean diameter of 80-
100 nm. From the images, it is apparent that the loaded and 
functionalized derivative S1 maintains the initial MCM-41 matrix 
morphology. A similar result was obtained for S1-CPT (data not 5 
shown). In all the samples, the characteristic channels of a 
mesoporous matrix were observed as alternate black and white 
lines.   
Table 1 BET-specific surface values, pore volumes and pore sizes 
(associated with intraparticle mesopores) calculated from the N2 10 
adsorption-desorption isotherms for each material. 
 
Mesopore 
Size 
(nm) 
Mesopore 
Volume 
(cm3g-1) 
Large 
pore 
Volume 
(cm3g-1) 
BET 
surface 
area 
(m2g-1) 
MCM-
41 
2.40 0.71 0.39 963.3 
S1 - < 0.03 0.23 45.6 
 
Table 2. Contents of the alcoxysilane derivative and cargo found on S1 
and S1-CPT 
 15 
 
Alcoxysilane 
derivative 
(mmol/g SiO2) 
Safranine O 
Content 
(mmol/g SiO2) 
CPT content 
(mmol/g SiO2) 
S1 3.47 0.25 - 
S1-CPT 1.35 - 0.27 
 
 
Further DLS (Dynamic Light Scattering) studies showed particles 
with a mean diameter of 100 nm. The studies also shown that the 
size of the nanoparticles was not modified throughout the loading 20 
and functionalization processes (figure 3). Signals at ca. 500 nm 
suggested that a small proportion of the nanoparticles were 
aggregated. 
 The N2 adsorption-desorption isotherms of the 
nanoparticulated MCM-41 calcined material are shown in Figure 25 
4. A typical curve for this mesoporous support, consisting of an 
adsorption step at an intermediate P/P0 value (0.1-0.3), is 
observed. This curve matches a type IV isotherm in which the 
observed step deals with nitrogen condensation inside the 
mesopores. The narrow BJH pore distribution and the absence of 30 
a hysteresis loop in this interval suggest the existence of uniform 
cylindrical mesopores (pore diameter of 2.40 nm and pore 
volume of 0.71 cm3 g-1 calculated by using the BJH model on the 
adsorption branch of the isotherm). Application of the BET 
model resulted in a value of 963.3 m2 g-1 for the total specific 35 
surface. From the XRD, porosimetry and TEM studies, the a0 cell 
parameter (4.1 nm), the pore diameter (2.40 nm), and  the wall 
thickness value of 1.7 nm were calculated. In addition to this 
adsorption step, a second feature is observed in the isotherm at a 
high relative pressure (P/P0 0.8), which corresponds to the filling 40 
of the large voids among the particles (0.48 cm3 g-1 calculated by 
the BJH model) and must be considered a textural-like porosity.  
 In this case, the curves show a characteristic H1 hysteresis 
loop and a wide pore size distribution. The N2 adsorption-
desorption isotherm of S1 is typical of mesoporous systems with 45 
practically filled mesopores (see Figure 4). Consequently, 
relatively low N2 adsorbed volume (BJH mesopore volume (0.03 
cm3 g-1) and surface area (45.6 m2 g-1) values were calculated, 
thus indicating effective pore blocking and the subsequent 
absence of appreciable mesoporosity. BET-specific surface 50 
values, mesopore volumes and mesopore sizes were calculated 
from the N2 adsorption-desorption isotherms for MCM-41 and S1 
and are listed in Table 1. 
 
Fig.5 29 Si-NMR of the MCM-41 as synthesized (a) and S1 (b) showing 55 
the evolution of the Q2+Q3and T sites through the loading and 
functionalization process. 
 
 The contents of N-(3-triethoxysilylpropyl)gluconamide and 
Safranine O dye or camptothecin  in solid S1 and solid S1-CPT 60 
respectively were determined by elemental and 
thermogravimetric analyses and are shown in Table 2. The 
amount of CPT present in S1-CPT before the functionalization 
with the gluconamide groups was ca. double of the final content 
(data not shown). The high content of the organosilane groups 65 
incorporated into S1 indicates that functionalization was not 
restricted to only direct interactions between silanol groups and 
the triethoxy moieties of the silanes on the external surface. Then, 
incorporation of the silanes anchored onto the internal surfaces 
(mesopore entrances), and even external polymerization, cannot 70 
be discarded (according to the experimental conditions used). The 
capability of the organo-silanes to modify the internal surface of 
mesopores, even in the case of materials with filled mesopores 
(with guest species), has been previously described.17 In fact, 
effective anchoring of the silanes inside mesopores of up to 8-10 75 
nm deep has been usually observed. Then, besides the external 
surface of the MCM-41 particles (ca. 70 m2/g) (determined from 
the N2 adsorption isotherms on the as-synthesized material), an 
extra surface of ca. 178 m2/g of the internal mesopores should be 
considered as being  80 
accessible for the gluconamide containing silanes (this last value 
has been roughly estimated from the internal surface (963 m2/g) 
by assuming an average particle diameter of 100 nm, and a 
maximum of 10 nm in deep functionalization, and by also bearing 
in mind that each mesopore has two entrances). In short for S1, 85 
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we obtained an average total surface of 248 m2/g for organosilane 
incorporation.  
 By taking into account that the normal density of the silanol 
groups in silica materials is ca. 6 Si-OH nm2 and that the 
gluconamide derivative has three reactive ethoxy groups, the 5 
maximum density of the gluconamide groups directly anchored 
onto hybrid solids should be expected to be ca. 2-3 
molecules/nm2. By assuming our anchoring model and the 
available 278 m2/g surface, only 0.82 mmol of the functional 
groups could be admitted by our MCM-41. Then, a significant 10 
amount of the N-(3-triethoxysilylpropyl)gluconamide groups are 
necessary incorporated through polymerization around the silica 
particles to form an organosilane shell. This assembling model is 
supported by NMR data. The 29Si NMR spectra of MCM-41 and 
S1 are shown in Figure 5. The evolution of the Q2+Q3 sites from 15 
28% (MCM-41) to 23% (S1) indicates that most of the silanol 
groups inside the mesopores remain unaltered. This fact is 
compatible with our model, where the N-(3-
triethoxysilylpropyl)gluconamide groups can be connected on a 
maximum silica surface of ca. 248 m2/g. In fact, a maximum 20 
estimated percentage of ca. 7% of the Q2+Q3 sites is accessible 
on this surface. Together with this decrease in the silanol groups, 
the T sites significantly increase (from 0 to 28%) after 
functionalization. Obviously, this high proportion of T sites is not 
compatible only with a direct polymerization of silanes on the 25 
external silica surface. Therefore, the presence of such a large 
amount of gluconamide moieties can be associated only with a 
significant polymerization of the N-(3-
triethoxysilylpropyl)gluconamide groups around the silica 
particles, which require a limited number of silanol groups to 30 
preserve the connection with the support. Moreover, this model is 
in accordance with the relatively low condensation of the 
organosilane network (T3:T2= 19:9).   
Functional enzyme-driven controlled release 
In this section, several experiments were carried out in order to 35 
study the enzyme-responsive controlled-release protocol using 
capped materials in detail. The controlled release behavior of S1 
was studied in aqueous media in the presence of two different 
enzymes (pronase, a non specific peptidase from Streptomyces 
griseus at pH 8.3; an amidase from Citrus sinensis at pH 7.5). 40 
The selected pHs are those at which the enzymes presented their 
optimal activity. In a first experiment, solid S1 (2.5 mg) was 
suspended in 25 mL of an aqueous solution (pH 8.3) containing 
pronase and the final suspension was stirred. The uncapping and 
subsequent delivery of the dye was easily detected by monitoring 45 
the safranine O emission band centered at 580 nm (excitation at 
520 nm). As a control experiment, dye release was also measured 
using suspensions of S1 under similar conditions, but in the 
absence of pronase. The difference in dye delivery in both 
experiments is displayed in Figure 6. Each point in the figure was 50 
determined using the above-described protocol, the suspension 
was filtered at a certain time and the emission of safranine O in 
the solution was measured. In the absence of the pronase enzyme, 
a flat baseline was found, indicating that the safranine O cargo 
remained in the nanoparticles without release. In contrast, in the 55 
presence of pronase, delivery of safranine O was observed as 
increased dye fluorescence in terms of time (see Figure 6). The 
maximum delivery of safranine O dye from final material S1 
amounted to 0.28 % in weight was determined by suspending a 
certain amount of S1 in water at pH 8.3 containing pronase and 60 
by allowing a complete dye delivery for at least 48 h. Under 
similar conditions, but in the absence of an enzyme, the 
maximum safranine O dye delivery from S1 was less than 0.01% 
in weight. This enzyme-induced release was ascribed to the 
hydrolysis of the amide bond located in the anchored derivative, 65 
which resulted in both the reduced size of the appended groups 
and the destruction of the dense hydrogen bond network provided 
by the attached gluconamide.  
Fig. 6 Release profiles in the absence and the presence of Pronase from 
Streptomyces Griseus and Peptide Amidase from Citrus Sinensis. The 70 
release of Safranine O was monitored via the fluorescence emission band 
centred at 580 nm (λexc = 520nm). 
 
 In spite of the considerable size reduction upon the hydrolysis 
of the amide bond, the dye release was slow and a constant cargo 75 
delivery was observed by at least 10 h. This low delivery rate 
may be ascribed to the location of the amide bond, which was 
deep inside the thread and close to the inorganic scaffolding 
surface. This position of the hydrolysable group hampers fast 
hydrolysis in the presence of pronase or amidase, and suggests 80 
that it is possible to modulate the release kinetics by locating 
amide moieties in different parts of the molecular threads.  
 Pronase is a mixture of proteinases that is able to induce the 
hydrolysis of the amide bond and the release of safranine O to the 
solution. In order to study the cargo delivery in more detail, some 85 
other enzymes were also tested. Figure 6 also displays the 
delivery profile found in the presence of amidase from Citrus 
sinensis at pH 7.5 using similar experimental conditions to those 
previously studied in the presence of pronase. Moreover at pH 
7.5, and in the absence of an enzyme, a flat curve was found, thus 90 
confirming the selective rupture of the amidase bond only in the 
presence of enzyme. As observed in the figure, greater delivery in 
this case was obtained when compared with pronase, which is 
most probably due to the different active concentration of both 
enzymes. In a final experiment, the cargo delivery from S1 was 95 
also tested in the presence enzyme Esterase from Porcine Liver; 
as expected, no delivery was observed under these conditions. 
During another experiment, it was also verified that the safranine 
O cargo remained in the S1 nanoparticles when the solid was in 
DMEM supplemented with 10% of FCS, which simulates typical 100 
cell culture conditions and indicates that no delivery was found 
using a medium with high salt concentrations.  
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 It should be noted that we previously prepared mesoporous 
nanoparticles functionalized with gluconamide groups on the 
external surface. In our previous example, a significant cargo 
delivery was observed when nanoparticles were suspended in 
water in the absence of enzymes.10b,13d However, as previously 5 
explained, a “zero release” was found in this new prepared S1 
material. This different behavior can be explained by the different 
degree and type of gluconamide functionalization in these solids. 
Thus, whereas our previous material contained 0.07 g of the 
gluconamide derivative per g of SiO2 (mainly anchored directly 10 
onto the silica surface), in S1, functionalization was larger and 
the final solid contained 0.81 g of gluconamide/g SiO2 
(combining direct functionalized groups and polymerized ones to 
form a relatively thick organosilane shell). It is apparent from 
these data that a simple control of the amount of capping 15 
molecule attached to nanoparticles allows the design of systems 
that either only tune the entrapped cargo delivery rate (our 
previously reported system) or show a remarkable inhibition of 
dye delivery (the system reported herein). 
 20 
 
Fig. 7  S1 Cellular internalization and WST-1 cell viability assay. HeLa 
and MCF-7 cells were treated with S1 at concentrations of 200, 100 and 
50 μg/mL for 24 h. Then, the confocal microscopy studies of the S1 
cellular uptake in HeLa (A) and MCF-7 (B) at the 100 μg/mL 25 
concentration were performed by Safranine O-S1-associated fluorescence 
(red) in the presence of DNA marker Hoechst 33342 (blue) and plasma 
membrane marker WGA Alexa Fluor 647 (green). For the cell viability 
studies, (C) HeLa (black bars) and MCF-7 (white bars) cells were 
incubated for 24 h with S1 at the concentrations stated before, while cell 30 
viability was quantified by employing the WST-1 reagent. Two 
independent experiments were performed and the data are represented as 
(mean  SE). 
 
Delivery of Gated Materials in Intracellular Media 35 
Having demonstrated the in vitro enzyme-controlled aperture of 
the gated material, cellular uptake of S1 and cargo release 
experiments were carried out. Our main objective was to validate 
these nanoparticles as drug reservoirs for on command release 
once inside the cells. For these experiments, two different 40 
tumorigenic cell lines, HeLa and MCF-7, were used. Firstly, cell 
viability studies were done to rule out any toxic effect due to the 
nanoparticles themselves or to the nature of the molecular gate. 
Briefly, cells were treated with S1 for 24 h before adding the 
WST-1 reagent. This yellow reagent can be reduced by 45 
metabolically active cells by mitochondrial enzymes to give a 
reduced orange soluble product. By measuring absorbance at 450 
nm and the subsequent normalization of these measures at 690 
nm, the innocuous effect of S1 on cells was proved at the 
concentrations tested (see Figure 7). To complement this cell 50 
viability assay, confocal microscopy internalization studies were 
also carried out by taking advantage of Safranine O S1-associated 
fluorescence (see Figures 6A and 6B for further details). In the 
images obtained, cells were also stained with DNA-associated 
dye Hoechst 33342 and the plasma membrane marker wheat 55 
germ agglutinin Alexa Fluor 647. A dotted pattern associated 
with S1 can be observed, which is comparable with that obtained 
by lysosomes staining, indicating that the possible internalization 
mechanism of the nanoparticle is endocytosis (Figures 6A and 
6B). 60 
 Having tested the biocompatibility of the S1 solid, a new 
nanoparticulated material containing the chemotherapeutic agent 
camptothecin (CPT) was synthesized (S1-CPT). As stated above, 
S1-CPT was prepared by following a similar procedure to that 
followed for S1, which consists in mesoporous nanoparticles 65 
loaded with CPT and capped with the gluconamide derivative. 
CPT is a quinoline alkaloid employed in the treatment of different 
cancer types given its ability to inhibit DNA polymerase I, thus 
disrupting DNA replication processes and inducing cell death. 
However, its low solubility prevents its application in patients.18 70 
In this case, HeLa cells were employed to demonstrate the 
possible cellular internalization of S1-CPT, the possible release 
of the cargo molecule after lysosomal localization and the 
subsequent uncapping by lysosomal enzymes. Therefore, cells 
were treated with these new nanoparticles for 48 h at different 75 
concentrations before performing the confocal microscopy and 
flow cytometry analyses. The confocal microscopy results 
obtained are shown in Figure 8. The cytotoxic effect of S1-CPT 
is clearly noted when compared to MCM-41-treated cells. CPT 
release induced cell death and detached cells showing membrane 80 
blebbing are observed (Figure 8).  
 For the flow cytometry studies, quantification of CPT-
associated cell death was performed by using propidium iodide 
(PI) and Annexin V (Ann V) markers, which stain dead cells and 
cells undergoing cell death, respectively. After 48 h of treatment, 85 
the S1-CPT-treated cells presented an increment in dead cells 
(ca. 20%) and cells undergoing cell death when compared to the 
MCM-41-treated cells. This fact proves the release of the cargo 
molecule inside the cell, this confirming the possible use of S1 as 
a drug-carrier of CPT. The main reason behind the relatively low 90 
percentage of cell death after 48 h of treatment was most likely 
due to the relatively low loading of CPT into the mesopores. 
According to the thermogravimetric and elemental analysis the 
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S1-CPT solid contains 0.27 mmoles CPT per gram of SiO2 (vide 
ante). This is a lower value to that found in some other capped 
mesoporous supports containing CPT (for instance 0.43 mmol of 
CPT / g SiO2 were determined in reference 13h) which resulted in 
a lower percentage of cell death.13h  5 
 
Fig. 8  S1-CPT cell internalization induces cell death. HeLa cells were 
treated with control MCM-41 (A, B) or S1-CPT (C, D) at 150 μg/mL, 
and cells were further incubated for 48 h. MCM-41-treated cells presented 
normal morphology and remained attached to the plate (A) in the confocal 10 
microscopy analysis (B), in which the plasma membrane was stained with 
WGA Alexa Fluor 647 (green). In contrast, S1-CPT-treated cells 
presented a phenotype associated with cell death (C) and a cell diffuse 
pattern of CPT-associated fluorescence (blue) due to CPT release and 
subsequent cell death induction. Quantification of cell viability and cell 15 
death (E, F) was performed by flow cytometry by means of PI and Ann V 
stainings, respectively. The percentage of dead cells (black), cells 
undergoing cell death (gray) and healthy cells (white) are shown after 48 
h of treatment. Three independent experiments containing triplicates were 
performed and the data are reported as (mean ± SE). 20 
 
Finally, in order to test that CPT release in cells was a 
consequence of the enzymatic hydrolysis of the gate, controlled 
release experiences with S1-CPT in a hydrophobic solvent 
(DMSO) were carried out. These experiences, developed in the 25 
absence of enzyme, showed that after 24 hours the amount of 
CPT release was negligible. 
 
CONCLUSIONS 
The efficiency of a new gated material to deliver its cargo in a 30 
controlled manner in the presence of certain enzymes has been 
proved. In this work, a new “zero-release” system based on the 
gated nanomaterial S1 has been prepared. This hybrid solid was 
composed of a nanoparticulated mesoporous scaffolding whose 
pores were loaded with safranine O dye and whose outer surface 35 
was covered with a gluconamide derivative. In the presence of 
pronase and amidase enzymes, the amide linkage in the 
gluconamide threads was hydrolyzed with the subsequent 
safranine O release. This study demonstrates that it is possible to 
use relatively simple molecules containing enzyme-hydrolyzable 40 
groups to design capped materials that can be opened at will. The 
present work also proves that gluconamide-functionalized 
nanoparticles are efficiently taken up by tumoral cells. The 
cellular uptake of nanoparticles probably occurs via endocytosis 
by targeting them to autolysosomes, where the molecular gate is 45 
degraded by lysosomal enzymes and the cargo is released. 
Finally, the possible application of gluconamide-functionalized 
nanoparticles as suitable delivery systems in the cells of 
chemotherapeutic agents, such as CPT, has been demonstrated, 
and a significant reduction of cell viability has been observed in 50 
the cells treated with solid S1-CPT. 
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EXPERIMENTAL SECTION 
Synthesis. General Methods 60 
XRD, TGA, elemental analysis, TEM, 29Si-NMR and N2 
adsorption-desorption techniques were employed to characterize 
synthesized materials. Powder X-ray measurements were taken in 
a Philips D8 Advance diffractometer using Cu Kα radiation. 
Thermogravimetric analyses were carried out on a TGA/SDTA 65 
851e Mettler Toledo balance using an oxidant atmosphere (air, 80 
mL/min) with a heating program consisting of a heating ramp of 
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10ºC per minute from 393 to 1273 K and an isothermal heating 
step at this temperature for 30 min. TEM images were obtained 
with a 100 kV Philips CM10 microscope. Dynamic Light 
Scattering (DLS) studies were conducted at 25 °C using a 
Malvern Zetasizer Nano ZS equipped with a 4 mW He-Ne solid-5 
state laser operating at 633 nm. Back-scattered light was detected 
at 173°, and the mean particle diameter was calculated from the 
quadratic fitting of the correlation function over 12 runs of 10 s 
duration. All measurements were performed in triplicate on 
previously sonnicated highly dilute aqueous dispersions.  N2 10 
adsorption-desorption isotherms were recorded with a 
Micromeritics ASAP2010 automated sorption analyzer. Samples 
were degassed at 70ºC in vacuum overnight. Specific surface 
areas were calculated from the adsorption data in the low pressure 
range using the BET model. Pore size was determined following 15 
the BJH method. 29Si MAS NMR spectra were recorded using a 
BrukerAvance 3 instrument 400MHz 
operating at 400 MHz and a magic angle spinning speed of 10.0 
kHz. Fluorescence spectroscopy was carried out with a Felix 32 
Analysis, version 1.2 (Build 56) PTI (Photon Technology 20 
International). Live cellular internalization studies were 
performed with a Cytomics FC 500 (Beckman Coulter Inc.) and a 
confocal Leica microscope was handled with a TCS SP2 system 
equipped with an acoustic optical beam splitter (AOBS). Cell 
viability measurements were carried out with a Wallac 1420 25 
workstation. 
Chemicals 
Chemicals tetraethylorthosilicate (TEOS), n-
cetyltrimethylammonium bromide (CTABr), sodium hydroxide 
(NaOH), safranine O, Pronase from Streptomyces Griseus, 30 
Peptide Amidase from Citrus Sinensis and Esterase from Porcine 
Liver were provided by Aldrich. N-(3-
triethoxysilylpropyl)gluconamide was supplied by Fluorochem. 
Camptothecin was provided by Sequoia Research Products. D-
MEM with L-glutamine, fetal calf serum (FCS), trypan blue 35 
solution (0.4%), cell culture grade, trypsin, wheat germ agglutinin 
(WGA) Alexa Fluor 647, and Hoechst 33342 were acquired from 
Gibco-Invitrogen. The cell proliferation reagent WST-1 was 
obtained from Roche Applied Science. Annexin V-FITC (AnnV) 
was supplied by Immunostep and propidium iodide (PI) came 40 
from BD Dickinson. All the products were used as received. 
Synthesis of the Mesoporous MCM-41 Nanoparticles 
The MCM-41 mesoporous nanoparticles were synthesized by the 
following procedure: n-cetyltrimethylammoniumbromide 
(CTABr, 1.00 g, 2.74 mmol) was first dissolved in 480 mL of 45 
deionized water. NaOH (aq) (2.00 M, 3.5 mL) was added to the 
CTABr solution after adjusting the solution temperature to 80°C. 
TEOS (5 mL, 2.57·10-2mol) was then added dropwise to the 
surfactant solution. The mixture was allowed to stir for 2 h to 
give a white precipitate. The solid product was centrifuged, and 50 
was washed with deionized water and ethanol. Finally, the solid 
was dried at 60°C (MCM-41 as-synthesized). To prepare the final 
porous material (MCM-41), the as-synthesized solid was calcined 
at 550°C using an oxidant atmosphere for 5 h to remove the 
template phase. 55 
Synthesis of S1 
In a typical synthesis, 0.340 g of templated-free MCM-41 and 
safranine O dye (0.036 g, 0.1mmol) were suspended in 90 mL of 
acetonitrile in a round-bottomed flask. To remove the adsorbed 
water, 10 mL of acetonitrile were distilled in a Dean-Stark set-up.  60 
After stirring 24 h at room temperature, an excess of the 
alkoxysilane derivative N-(3-triethoxysilylpropyl)gluconamide 
(50% ethanol) (2.86 mL, 3.4 mmol) was added and the final 
mixture was stirred for 24 h at room temperature. Finally, solid 
S1 was filtered off, washed with 800 mL of acetonitrile (200mL 65 
four times) and dried at 38°C overnight. 
Synthesis of S1-CPT 
In a typical synthesis, 0.100 g of templated-free MCM-41 and the 
a solution of the corresponding amount of camptothecin (56 mg, 
0.16 mmol / 5mL  ethanol) were suspended in 20 mL of 70 
anhydrous acetonitrile. After stirring for 24 h, the corresponding 
amount of N-(3-triethoxysilylpropyl)gluconamide (50% Ethanol) 
was added (0.974 mL, 1.15 mmol) and the mixture was stirred for 
24 h at room temperature. Finally, solid S1-CPTwas filtered. In 
order to eliminate the non reacted reagents, a suspension of S1-75 
CPT in 200 mL of a chloroform-methanol mixture 3:4 (v/v) was 
stirred overnight. After filtering the solid, it was dried at vacuum 
for 1 h and kept in inert atmosphere. 
Dye release studies 
In a typical experiment, 2.5 mg of S1 were suspended on 25 mL 80 
of water. pH must be previously adjusted to optimum enzyme 
conditions (pH=7.5 for amidase from Citrus sinensis, pH=8.3 for 
pronase from Streptomyces griseus). Then 50 μL of Peptide 
Amidase from Citrus sinensis were added, whereas to evaluate 
the Pronase and Esterase effects, 3 mg of S1 were suspended on 85 
25 mL of a solution of Pronase from Streptomyces griseus or 
Esterase from Porcine Liver, respectively (0.12 mg/mL). These 
suspensions were used to evaluate the gate-like effect by studying 
the dye release from the pore voids of the functionalized material. 
The delivery of safranine O dye from the pore voids to the 90 
solution was easily monitored by the fluorescent emission band 
of the dye centered at 580 nm (excitation at 520 nm). 
Cell Culture Conditions 
The HeLa human cervix adenocarcinoma and the MCF-7 human 
breast adenocarcinoma were purchased from the German 95 
Resource Centre for Biological Materials (DSMZ) and were 
grown in D-MEM and Medium 199 supplemented with 10% of 
FCS. Cells were maintained at 37°C in an atmosphere of 5% 
carbon dioxide and 95% air, and they underwent passage twice a 
week. 100 
WST-1 Cell Viability Assay 
Cells were cultured in sterile 96-well microtiter plates at a 
seeding density of 2.5x103 and 3x103 cells/well for HeLa and 
MCF-7, respectively, and they were allowed to settle for 24 h. S1 
in DMSO was added to cells at the final concentrations of 50, 25, 105 
10, and 5 µg/mL. After 23 h, WST-1 (7 µL of a 5 mg/mL 
solution) was added to each well. Cells were further incubated for 
1 h (a total of 24 h of incubation was therefore studied), and 
absorbance was measured at 450 nm and normalized versus 
absorbance at 690 nm in a Wallac 1420 workstation. 110 
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Live Confocal Microscopy S1 Cellular Internalization 
HeLa and MCF-7 cells were seeded in 24 mm  glass coverslips 
in 6-well plates at a seeding density of 5·104  cells/well. After 24 
h, cells were treated when indicated with S1 or S1-CPT at a final 
concentration of 50 µg/mL. After 24 h of incubation, cells were 5 
stained with 10 ng/mL of Hoechst 33342 and 5 mg/mL WGA 
Alexa Fluor 647 for 30 min in PBS containing 10% FCS or by 
keeping the medium for the S1-DOX treatments. Slides were 
visualized under a confocal microscope. Two independent 
experiments were done and contained triplicates with similar 10 
results. 
Cytofluorometry Studies Employing S1 
To carry out the cytofluorometry studies, HeLa cells were seeded 
at 5x104 cells/well in a 12-well plate. After 24 h, cells were 
treated with S1-CPT at the following concentrations for 48 h: 15 
150, 100 and 50 µg/mL. Then, cells were stained with PI and Ann 
V according to the manufacturer’s protocol (BD Pharmingen). 
Quantification of PI-positive and AnnV-positive staining was 
done by the WinMDI program, version 2.9. Three independent 
experiments were done and contained triplicates with analogous 20 
results. 
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